Cited by 38Viral Infections and Outbreaks ResearchViral Infections and VectorsVirology and Viral Diseases

The DOI matches its Crossref record.

Haemorrhagic fever in Gabon. I. Incidence of Lassa, Ebola and Marburg viruses in Haut-Ogooué

Ivanoff, B., Duquesnoy, Ph., Languillat, G., Saluzzo, J.F., Georges, A., Gonzalez, J.P., McCormick, J.·1982·Transactions of the Royal Society of Tropical Medicine and Hygiene

Abstract

A serological enquiry aimed at determining the incidence of infection with Lassa, Ebola and Marburg viruses was conducted on the human population of the region of Haut-Ogooué (Gabon) and on primates. The results, obtained by the indirect immunofluorescence technique, showed that more than 6% of the human population had had contact with Ebola virus but no antibodies against Marburg or Lassa viruses were found. Most sera reacted to an Ebola antigen from a Zairian strain, but showed little or no reaction to an antigen from a Sudanese strain.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1016/0035-9203(82)90089-x

Cites

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • The studies included in this review demonstrated low levels of antibodies in surveyed populations, with approximately one third of studies reporting a seroprevalence of 0%.

    “The studies included in this review demonstrated low levels of antibodies in surveyed populations, with approximately one third of studies reporting a seroprevalence of 0% (26,36,39,41,46,50,52).”

    From Marburg virus disease outbreaks, mathematical models, and disease parameters: a systematic review (2024) · cites this paper as [36]

    The Results report no Lassa or Marburg antibodies in 253 human samples, supporting a 0% finding for those viruses; they also report Ebola antibodies in 6.3% of the population examined. This single study does not establish the review-wide claim that approximately one third of studies reported 0% seroprevalence. (LLM, conf=0.86)

    Experimental — accuracy not yet measured
  • Seroprevalence estimates of MVD and EVD are often reported together, with estimates for MVD consistently lower than for EVD.

    “Seroprevalence estimates of MVD and EVD are often reported together, with estimates for MVD consistently lower than for EVD, e.g. (35,36,44,54).”

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

No references could be resolved yet.

Research works printed but not linked: 4

  1. Bres, 1978, Les virus Lassa, Marburg et Ebola, nouveaux venus en Pathologie Tropicale Africaine. I. Sémiologie-Physiopathologie-Diagnostic-Traitement, Nouvelle Presse Médicale, 7, 2921
  2. Bres, 1978, Les virus Lassa, Marburg et Ebola, Nouveaux venus en Pathologie Tropicale Africaine. II. Epidemiologie. Problèmes de Santé Publique, Nouvelle Presse Médicale, 7, 3007
  3. Saluzzo, 1980, Note préliminaire sur la présence d'anticorps vis-à-vis du virus Ebola parmi les populations humaines de l'est de la République Centrafricaine, Bulletin de la Société de Pathologie Exotique, 3, 238
  4. Wulff, 1975, Indirect immunofluorescence for the diagnosis of Lassa fever infection, Bulletin of the World Health Organization, 52, 429

Cited by

Sorted by citations

Metadata

Authors
Ivanoff, B., Duquesnoy, P., Languillat, G., Saluzzo, J. F., Georges, A., Gonzalez, J. P., & McCormick, J.
Affiliations
  • Centre International de Recherches Médicales de Franceville (GA)
  • Institut Pasteur (FR)
  • Centers for Disease Control and Prevention (US)
Venue
Transactions of the Royal Society of Tropical Medicine and Hygiene
Published
1982-01
Volume
76
Issue
6
Pages
719-720
ISSN
0035-9203 (ISSN-L)
OpenAlex
W2090430083
Cited by
38
References
0
Citations by year
2024: 2 · 2023: 3 · 2020: 1 · 2017: 1 · 2016: 3 · 2014: 1
FWCI
0.50
Type
journal article
Language
en
Open access
closed
Locations
  • Transactions of the Royal Society of Tropical Medicine and Hygiene (publishedVersion)
  • PubMed (publishedVersion)
Funders
  • University of Stirling
  • Centre International de Recherches Médicales de Franceville
Topics
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Outbreaks Research
  • Health Sciences › Medicine › Infectious Diseases › Viral Infections and Vectors
  • Health Sciences › Medicine › Epidemiology › Virology and Viral Diseases
Keywords
Lassa virus, Ebola virus, Marburg virus, hemorrhagic fever, seroprevalence, antibody incidence, primates, Gabon
MeSH terms
Adult, Animals, Antibodies, Viral, Pan troglodytes, Disease Outbreaks, Female, Gabon, Hemorrhagic Fevers, Viral, Humans, Infant, Newborn, Lassa Fever, Lassa virus, Marburg Virus Disease, Pregnancy, Marburgvirus, Ebolavirus

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review